15 A novel CD28 humanized mouse model for efficacy assessment of CD28-targeting therapies
Main Authors: | Jiao Wang, Yeonhee Yun, Karen E Pollok, Anthony L Sinn, Randy R Brutkiewicz, Michael C Veronesi |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Similar Items
-
138 In vivo localization of genetically engineered natural killer cells against glioblastoma using PET imaging
by: Jiao Wang, et al.
Published: (2020-11-01) -
134 Tumor-responsive, multi-functional genetically-engineered natural killer cells for immunotherapy of glioblastoma
by: Jiao Wang, et al.
Published: (2020-11-01) -
The CD28-Transmembrane Domain Mediates Chimeric Antigen Receptor Heterodimerization With CD28
by: Yannick D. Muller, et al.
Published: (2021-03-01) -
The value of changes in CD8+CD28+ and CD4+CD28+ cells in patients with HIV infection concurrent with tuberculosis during treatment
by: A A Popova, et al.
Published: (2013-11-01) -
Association of CD28 IVS3 +17T/C Polymorphism with Soluble CD28 in Rheumatoid Arthritis
by: I. Y. Ledezma-Lozano, et al.
Published: (2011-01-01)